Her scientific interests lie mostly in Internal medicine, Endocrinology, Breast cancer, Cancer and Risk factor. Internal medicine and Oncology are commonly linked in her work. Her studies deal with areas such as Vitamin C and Endometrial cancer as well as Endocrinology.
Her Breast cancer study combines topics from a wide range of disciplines, such as Sex hormone-binding globulin, Testosterone, Dehydroepiandrosterone sulfate, Gynecology and Menstrual cycle. Her Cancer research incorporates themes from Long term treatment, Estrogen, Pediatrics and Heparin. Paola Muti has researched Risk factor in several fields, including Blood pressure, Liver function and Cholesterol.
Paola Muti mainly investigates Internal medicine, Breast cancer, Endocrinology, Cancer and Oncology. Prospective cohort study, Case-control study, Risk factor, Body mass index and Estrogen are the subjects of her Internal medicine studies. The concepts of her Prospective cohort study study are interwoven with issues in Nested case-control study, Cohort and Cohort study.
Her Breast cancer research is multidisciplinary, incorporating perspectives in Odds ratio, Gynecology, Epidemiology and Physiology. As part of her studies on Endocrinology, Paola Muti often connects relevant subjects like Endometrial cancer. The study incorporates disciplines such as Relative risk, Cancer research and microRNA in addition to Cancer.
Paola Muti spends much of her time researching Cancer research, Internal medicine, Cancer, microRNA and Oncology. Her Internal medicine study frequently draws connections to adjacent fields such as Canagliflozin. The Cancer study combines topics in areas such as DNA damage, Bioinformatics, DNA repair, Cell biology and Melatonin.
Her work deals with themes such as Carcinogenesis and Lung cancer, Pathology, which intersect with microRNA. Paola Muti interconnects Chemotherapy, Diabetes mellitus, Progesterone receptor, Case-control study and Prostate cancer in the investigation of issues within Oncology. Her biological study spans a wide range of topics, including Androgen, Testosterone, Prospective cohort study, Estrogen and Adjuvant therapy.
Her primary scientific interests are in Cancer research, Cancer, microRNA, Metformin and Pathology. Her Cancer research research is multidisciplinary, relying on both Cell culture, Cell migration, Cell growth, Protein kinase A and Head and neck squamous-cell carcinoma. Her Cancer study incorporates themes from Melatonin, Hormone, DNA repair and Cell biology.
Metformin is a subfield of Internal medicine that Paola Muti explores. Her research integrates issues of Gene expression profiling, Carcinogenesis, Gene, Normal tissue and Recurrence risk in her study of Pathology. Her work in Breast cancer covers topics such as Meta-analysis which are related to areas like Oncology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women.
T J Key;P N Appleby;G K Reeves;A Roddam.
Journal of the National Cancer Institute (2003)
Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States).
Libby M. Morimoto;Emily White;Z. Chen;Rowan T. Chlebowski.
Cancer Causes & Control (2002)
Myocardial Injury after Noncardiac Surgery: A Large, International, Prospective Cohort Study Establishing Diagnostic Criteria, Characteristics, Predictors, and 30-day Outcomes
Fernando Botto;Pablo Alonso-Coello;Matthew T V Chan;Matthew T V Chan;Juan Carlos Villar.
Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Elie A Akl;Lara A Kahale;Maddalena Barba;Ignacio Neumann.
Cochrane Database of Systematic Reviews (2014)
Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer
Elie A Akl;Srinivasa Rao Vasireddi;Sameer Gunukula;Maddalena Barba.
Cochrane Database of Systematic Reviews (2014)
Catechol estrogen quinones as initiators of breast and other human cancers: Implications for biomarkers of susceptibility and cancer prevention ☆
Ercole Cavalieri;Dhubajyoti Chakravarti;Joseph Guttenplan;Elizabeth Hart.
Biochimica et Biophysica Acta (2006)
Correlates of Markers of Oxidative Status in the General Population
Maurizio Trevisan;Richard Browne;Malathi Ram;Paola Muti.
American Journal of Epidemiology (2001)
Serum Sex Hormone Levels After Menopause and Subsequent Breast Cancer
Franco Berrino;Paola Muti;Andrea Micheli;Gianfranco Bolelli.
Journal of the National Cancer Institute (1996)
Fasting glucose is a risk factor for breast cancer: a prospective study.
Paola Muti;Teresa Quattrin;Brydon J. B. Grant;Brydon J. B. Grant;Vittorio Krogh.
Cancer Epidemiology, Biomarkers & Prevention (2002)
Estrogen Metabolism and Risk of Breast Cancer: A Prospective Study of the 2:16α-Hydroxyestrone Ratio in Premenopausal and Postmenopausal Women
Paola Muti;H. Bradlow;Andrea Micheli;Vittorio Krogh.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: